[ad_1]
Stop at vaccine AstraZeneca Also in Italy. The Italian Medicines Agency Aifa has decided to extend the ban on the use of the vaccine throughout the country as a precautionary measure and on a temporary basis, pending the sentences of the EMA. France and Germany also announced a similar decision today. The decision comes to Italy after another he was kidnapped lotus of the Anglo-Swedish serum, theABV5811, the inoculated to the professor who died in Friuli and originally from Biella. This is the second batch blocked at the national level after ABV2856, withdrawn after the adverse cases registered in Sicily. Meanwhile, sinceMother, the European drug agency, confirms the efficacy of the Pfizer, Moderna and Johnson & Johnson vaccines against variants.
Stop also in Germany and France
The decision by Italy, France and Germany to suspend the use of AstraZeneca follows similar decisions by Norway, Denmark, Iceland, Finland, the Netherlands and Ireland. The Italian Medicines Agency will immediately release any additional information that may become available, including additional methods to complete the vaccination cycle for those who have already received the first dose, ”Aifa said in a press release.
The German Health Ministry, in suspending AstraZeneca, followed the advice of the Paul Ehrlich Institut, which as a precaution recommends “more research” in relation to new cases of thrombosis that have occurred. In recent days, Berlin, on the other hand, had criticized the Danish and Finnish scale.
“We know the scope of this decision that was not made lightly. But it is a factual decision and not a political one, ”said German Health Minister Jens Spahn. “This is a purely precautionary decision.” “To maintain confidence in the vaccine, we must give our experts time to verify new cases and eliminate any risks.»he continued. «It should be clear – he added – that even not vaccinating carries risks».
Kidnappings in Italy
393,600 doses of the AstraZeneca batch of the Covid-19 ABV5811 vaccine, already blocked in Piedmont, have been delivered in Italy. This was announced by the Carabinieri Nas who are proceeding with the kidnapping. in all distribution HUBs and vaccination centers. A provision that aims to “consolidate the quantities not yet managed and present in stock.”
Catania, a compromised cold chain
Meanwhile, in the center of Catania the ladminister a batch of vaccines as a precaution against a problem in the cold chain. The axis is the one built in the old fruit and vegetable market of San Giuseppe La Rena. The initiative was taken after operators noticed that the refrigerator where the doses were stored had a problem with the power supply. For preventive purposes, it was decided not to use this batch for vaccines.
Vaccines and variants, the EMA data
From the first studies carried out, messenger RNA vaccines (Moderna and Pfizer-Biontech) have “excellent efficacy against new Covid variants.” Similarly, “the Johnson & Johnson vaccine recently approved by the EMA” was also effective, Marco Cavaleri, Ema’s head of vaccine strategy, said at a hearing at the European Parliament’s health committee. “According to a small study of two thousand cases, the AstraZeneca vaccine was ineffective” against the South African variant, Cavaleri explained, indicating however that it will be necessary to wait “larger studies” to verify its real effectiveness.
At the same time, the EMA reiterates that “IThe balance of benefits and risks “of the AstraZeneca anti-Covid vaccine” is considered positive and we do not see any problem in continuing with vaccinations with this vaccine. ” “We are examining the data and lethal events reported to try to understand if there are specific clusters of cases” linked “to certain types of pathologies or to the medical condition of the subjects,” added Cavaleri, underlining that there is no evidence so far. that “demonstrate an emerging risk that affects the benefit / risk ratio.”
Among the novelties of today is also the collaboration agreement between the German IDT Biologika and Johnson & Johnson, to increase the availability of vaccines in Europe. This was announced by IDT Biologika in a press release. According to the note, the group will allocate the Dessau factory, until now reserved for the pharmaceutical company Takeda, a candidate for the dengue vaccine, to the Johnson and Johnson vaccine.
The discontinuation of the AstraZeneca vaccine in more and more European countries is making noise in the UK, where Anglo-Swedish serum is by far the most widely used. Boris Johnson, who was asked if he could reassure British citizens, replied: ‘Yes, I can, because the MHRA (British drug agency) has some of the strictest and most experienced controls in the world and they don’t sell motives. of the vaccines we are using. ”“ The MHRA has verified the effectiveness of these vaccines, ”continued BoJo,“ not only in reducing hospitalizations, but in general, serious infections and mortality: that is why we are advancing with confidence and “at great speed. speed “in administration.
Last updated: 16:42
© REPRODUCTION RESERVED
[ad_2]
